Cheng Liu

Cheng Liu

Auto-generated profile, based on publicly available information

Cheng Liu

Department of Dental Technology, Shu-Zen Junior College of Medicine and Management, Kaohsiung 82144, Taiwan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CYChing-Huey Yang
Ching-Huey Yang
KTKuo-Lung Tung
Kuo-Lung Tung
YWYen-Ting Wu
Yen-Ting Wu
CLCheng Liu
Cheng Liu
SLSheng-Chieh Lin
Sheng-Chieh Lin
YLYu-Yan Lan
Yu-Yan Lan
Since a portion of patients with nasopharyngeal carcinoma (NPC) do not benefit much from current standard treatments, it is still needed to discover new therapeutic drugs to improve the prognosis of the patients. Considering that Chinese traditional medicine plays a role in inhibiting tumor progression, in this study, we aimed to investigate whether a Chinese herbal formula, Qing Yan Li Ge Tang (QYLGT), has the anticancer activity in NPC cells and explore the underlying mechanism as well. MTT assay, colony formation assay, immunoblotting assay, and DNA laddering assay were performed to assess cell viability, cell colony formation, protein expression, and DNA fragmentation, respectively. Results show that QYLGT was able to inhibit the cell viability and decrease colony formation ability in NPC cells. QYLGT could also increase the formation of intracellular vacuoles and induce the autophagy-related protein expressions, including Atg3, Atg6, and Atg12-Atg5 conjugate in NPC cells. Treatment with an autophagy inhibitor, 3-methyladenine, could significantly recover QYLGT-inhibited cell viability of NPC cells. In addition, QYLGT did not significantly induce apoptosis in NPC cells. We also found that QYLGT had the ability to activate phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of the rapamycin (mTOR) pathway. Treatment with PI3K inhibitors, LY294002 and wortmannin, or mTOR inhibitors, rapamycin and Torin 1, could not only recover QYLGT-inhibited cell viability of NPC cells but also inhibit Atg3 expression. Taken together, our results demonstrated that QYLGT could induce autophagic cell death in NPC cells through the PI3K/Akt/mTOR pathway.

1 January 2012
Verified
Book Chapter
Closed access
PDF file
CLCheng Liu
Cheng Liu
YLYong Liang
Yong Liang
XLXin-Ze Luan
Xin-Ze Luan
KLKwong-Sak Leung
Kwong-Sak Leung
TCTak-Ming Chan
Tak-Ming Chan
Hai ZhangHai Zhang
Hai Zhang

16 June 2022 in Gastroenterology
Verified
Journal Article
Closed access
DNDaiki Nemoto
Daiki Nemoto
CLCheng Liu
Cheng Liu
KNKaoru Nakano
Kaoru Nakano
HKHiroshi Kawachi
Hiroshi Kawachi
BLBarbara Leggett
Barbara Leggett
KTKazutomo Togashi
Kazutomo Togashi